Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis
- PMID: 7924483
- DOI: 10.1378/chest.106.4.1124
Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis
Abstract
Certain antibiotics, particularly piperacillin, have been reported to be associated with a high incidence of allergic reactions in patients with cystic fibrosis. We initiated a study to determine the relative frequency of allergic reactions, ie, drug-induced fever and rash, to parenteral beta-lactam antibiotics in adult patients with cystic fibrosis. Charts of 111 patients were reviewed for each hospitalization to assess allergic reactions. Of 90 evaluable patients, 26 patients developed one or more allergic reactions to beta-lactam antibiotics. The number of allergic reactions per number of patients receiving specific antibiotics were carbenicillin (4/56), mezlocillin (7/42), piperacillin (11/31), ticarcillin (1/20), cefazolin (0/24), ceftazidime (1/35), imipenem/cilastatin (4/16), and nafcillin (3/36). The mean time to onset of drug-induced fever or of rash was 9.1 days. As a group penicillins had a higher frequency of allergic reactions than cephalosporins. The frequency of reactions was greatest with acylaminopenicillins (mezlocillin and piperacillin) and imipenem/cilastatin. The results of this study indicate that in addition to piperacillin, mezlocillin and imipenem/cilastatin may be associated with a high incidence of allergic reactions in patients with CF.
Similar articles
-
Antibiotic allergy in cystic fibrosis.Thorax. 2005 Jun;60(6):517-20. doi: 10.1136/thx.2004.027953. Thorax. 2005. PMID: 15923254 Free PMC article. Review.
-
Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses.Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S608-11. doi: 10.1093/clinids/13.supplement_7.s608. Rev Infect Dis. 1991. PMID: 2068467
-
Beta-lactam allergy in adults with cystic fibrosis.J Cyst Fibros. 2007 Jul;6(4):297-303. doi: 10.1016/j.jcf.2006.11.001. Epub 2006 Dec 19. J Cyst Fibros. 2007. PMID: 17182289
-
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.J Antimicrob Chemother. 1987 Jan;19(1):101-7. doi: 10.1093/jac/19.1.101. J Antimicrob Chemother. 1987. PMID: 3104273
-
Antibiotic hypersensitivity in patients with CF.Clin Rev Allergy Immunol. 2002 Aug;23(1):123-41. doi: 10.1385/CRIAI:23:1:123. Clin Rev Allergy Immunol. 2002. PMID: 12162103 Review.
Cited by
-
Antibiotic allergy in cystic fibrosis.Thorax. 2005 Jun;60(6):517-20. doi: 10.1136/thx.2004.027953. Thorax. 2005. PMID: 15923254 Free PMC article. Review.
-
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.J Pharmacol Exp Ther. 2012 Jun;341(3):597-610. doi: 10.1124/jpet.111.190900. Epub 2012 Feb 27. J Pharmacol Exp Ther. 2012. PMID: 22371438 Free PMC article.
-
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?Drugs. 2000 Nov;60(5):1053-64. doi: 10.2165/00003495-200060050-00006. Drugs. 2000. PMID: 11129122 Review.
-
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.Infection. 2010 Apr;38(2):131-4. doi: 10.1007/s15010-009-9227-8. Epub 2010 Mar 5. Infection. 2010. PMID: 20213286
-
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.J Immunol. 2011 Jul 1;187(1):200-11. doi: 10.4049/jimmunol.1100647. Epub 2011 May 23. J Immunol. 2011. PMID: 21606251 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials